Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency

Clinical Endocrinology

Volumn 68, Issue 2, 2008, Pages 247-251

  Giavoli, Claudia ^a   Bergamaschi, Silvia ^a   Ferrante, Emanuele ^a   Ronchi, Cristina L ^a   Lania, Andrea G ^a   Rusconi, Roberto ^a   Spada, Anna ^a   Beck Peccoz, Paolo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IDIOPATHIC DISEASE; INSULIN TOLERANCE TEST; ISOLATION PROCEDURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; CHILD; DWARFISM, PITUITARY; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-LIKE GROWTH FACTOR I; MALE; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY;

EID: 38049151233     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03029.x     Document Type: Article

References (24)

1. Le Roy, C., Li, J.Y., Stocco, D.M., Langlois, D. Saez, J.M. (2000) Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growyh factor-β and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P450c17 and 3β-hydroxysteroid dehydrogenase. Journal of Clinical Endocrinology and Metabolism, 141, 1599 1607.
2. Schleim, K.D., Jacks, T., Cunningham, P., Feeney, W., Frazier, E.G., Niebauer, G.W., Zhang, D., Chen, H., Smith, R.G. Hickey, G. (1999) Increases in insulin-like growth factor-I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation. Endocrinology, 140, 1552 1558.
3. Gianotti, L., Ramunni, J., Lanfranco, F., Maccagno, B., Giordano, R., Broglio, F., Maccario, M., Muller, E.E., Ghigo, E. Arvat, E. (2001) Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans. Journal of Endocrinolological Investigation, 24, 67 71.
4. Weaver, J.U., Thaventhiran, L., Noonan, K., Burrin, J.M., Taylor, N.F., Norman, M.R. Monson, J.P. (1994) The effect of GH replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639 648.
5. Rodriguez-Arnao, J., Perry, L., Besser, G.M. Ross, R.J.M. (1996) Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clinical Endocrinology, 45, 33 37.
6. Tschöp, M., Lahner, H., Feldmeier, H., Grasberger, H., Morrison, K.M., Janssen, O.E., Attanasio, A.F. Strasburger, C.J. (2000) Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults. European Journal of Endocrinology, 143, 769 773.
7. Isidori, A.M., Kaltsas, G.A., Perry, L., Burrin, J.M., Besser, G.M. Monson, J.P. (2003) The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Clinical Endocrinology, 58, 601 611.
8. Stewart, P.M., Murry, B.A. Mason, J.I. (1994) Human kidney 11β-hydoxysteroid dehydrogenase is a high affinity NAD+-dependent enzyme and differs from the cloned 'type I' isoform. Journal of Clinical Endocrinology and Metabolism, 80, 3617 3620.
9. Ricketts, M.L., Verhaeg, J.M., Bujalska, I., Howie, A., Rainey, W.E. Stewart, P.M. (1998) Immunohistochemical localization of type 1 11β-hydoxysteroid dehydrogenase in human tissues. Journal of Clinical Endocrinology and Metabolism, 83, 1325 1335.
10. Edward, C.R.W., Stewart, P.M., Burt, D., Brett, L., McIntyre, M.A., Su tanto, W.S., DeKloet, E.R. Monder, C. (1988) Localisation of 11β-hydoxysteroid dehydrogenase-tissue specific protector of the mineralcorticoid receptor. Lancet, 2, 986 989.
11. Seckl, J.R. (1995) The sindrome of apparent mineralcorticoid excess and deficiency of 11β-hydoxysteroid dehydrogenase. Clinical Endocrinology, 43, 247 248.
12. Moore, J.S., Monson, J.P., Kaltsas, G., Putignano, P., Wood, P.J., Sheppard, M.C., Besser, G.M., Taylor, N.F. Stewart, P.M. (1999) Modulation of 11β-HSD isoenzymes by GH and IGF-I: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism, 84, 4172 4177.
13. Trainer, P.J., Drake, W.M., Perry, L.A., Taylor, N.F., Besser, G.M. Monson, J.P. (2001) Modulation of cortisol metabolism by the GH receptor antagonist pegvisomant in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 86, 2989 2992.
14. Gelding, S.V., Taylor, N.F., Wood, P.J., Noonan, K., Weaver, J.U., Wood, D.F. Monson, J.P. (1998) The effect of GH replacement on cortisol-cortisone interconversion in hypopituitary adults: evidence for GH modulation of extrarenal 11β-HSD activity. Clinical Endocrinology, 48, 153 162.
15. Walker, B.R., Andrew, R., Macleod, K.M. Padfield, P.L. (1998) GH replacement inhibits renal and hepatic 11βHSDs in ACTH deficient patients. Clinical Endocrinology, 49, 257 263.
16. Giavoli, C., Libè, R., Corbetta, S., Ferrante, E., Lania, A., Arosio, M., Spada, A. Beck-Peccoz, P. (2004) Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism, 89, 5397 5401.
17. Walvoord, E., Rosenman, M.B. Eugster, E. (2004) Prevalence of adrenocorticotropin deficiency in children with idiopathic isolated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 89, 5030 5034.
18. Tanner, J.M., Whitehouse, R.H. Cameron, N. (1983) The method in practice: standards for skeletal maturity and bone age. In : J.M. Tanner, R.H. Whitehouse, N. Cameron, eds. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). Academic Press Inc., San Diego, 9 21.
19. Agwu, J.C., Spoudeas, H., Hindmarsh, P.C., Pringle, P.J. Brook, C.G.D. (1999) Tests of adrenal insufficiency. Archives of Diseases in Childhood, 80, 330 333.
20. Nye, E.J., Grice, J.E., Hockings, G.I., Strakosch, C.R., Crosbie, G.V., Walters, M.M. Jackson, R.V. (1999) Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. Journal of Clinical Endocrinology and Metabolism, 84, 3648 3655.
21. Giavoli, C., Porretti, S., Ferrante, E., Cappiello, V., Ronchi, C.L., Travaglini, P., Epaminonda, P., Arosio, M. Beck-Peccoz, P. (2003) Recombinant hGH replacement therapy and the hypothalamic-pituitary-thyroid axis in children with GH deficiency: when should we care about the occurrence of central hypothyroidism? Clinical Endocrinology, 59, 806 810.
22. Streeten, D.H.P., Anderson, G.H., Dalakos, T.G., Seeley, D., Mallov, J.S., Eusebio, R., Sunderlin, F.S., Badawy, S.Z. King, R.B. (1984) Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocrine Review, 5, 371 394.
23. Low, S.C., Chapman, K.E., Edwards, C., Wells, T., Ribinson, I.C. Seckl, J.R. (1994) Sexual dimorphism of hepatic 11β-hydroxysteroid deydrogenase in the rat: the role of growth hormone patterns. Journal of Endocrinology, 143, 541 548.
24. Agha, A. Monson, J.P. (2007) Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clinical Endocrinology, 66, 459 465.